ATRC vs DD · rev $465.3M vs P/E 127, rev $12.39B
AtriCure Inc (ATRC) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ATRC revenue for 2024-12-31 was $465.3M. Net income was -$44.7M. Revenue was up 16.5% from 2023-12-31 to 2024-12-31. ATRC currently screens at market cap $1.37B.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ATRC currently screens at market cap $1.37B. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ATRC and DD stock pages for the full models.
Not investment advice.